BERLIN, Germany, 3 June 2024 –MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today showcased its cutting-edge technologies via a Corporate Satellite Meeting at this year’s European Society of Human Genetics (ESHG) conference in Berlin, Germany.
MGI users across Europe, ranging from leading researchers to clinicians, academics, and industry leaders, shared first-hand insights on adopting MGI’s core DNBSEQTM technology in screening, diagnostics, and population health initiatives among various applications, highlighting the strides MGI has made in advancing research in the life science sector across the region. Image Credit: MGI During the meeting, Dr. Davide Cacchiarelli from the Telethon Institute of Genetics and Medicine in Italy credited DNBSEQ for his organization’s ability to offer affordable screening services for the Italian population.
Dr. Paula Sancho Salmerón from Sistemas Genómicos in Spain demonstrated a diagnostic workflow for monogenic hereditary diseases, while Daniel Langhoff, Senior Director for Population & Consumer Genomics at Eurofins in Germany, presented a multi-omics approach in population health utilizing MGI’s sequencing technology. Image Credit: MGI Additionally, Dr.
Marie-Laure Yaspo from Germany’s ALACRIS Theranostics shared insights into the quality upgrade made possible by the new StandardMPS 2.0 (SM 2.0) seque.